Healthcare-associated Infectious Disease Diagnostics Market By Infection Type (Urinary Tract Infections, Surgical Site Infections, Hospital-acquired Pneumonia, Blood Stream Infections, Gastrointestinal Infections, and Other Healthcare-associated Infections), By Product Type (Consumables and Analyzers/Instruments), By Test Type (Traditional Diagnostics and Molecular Diagnostics), By End-User Type (Hospitals, Clinics, ASCs, and Others), and By Region - Trends, Analysis and Forecast till 2030

Healthcare associated Infectious Disease Diagnostic market accounted for USD 3481.3 Million in 2020 and is estimated to be USD 6666.5 Million by 2030 and is anticipated to register a CAGR of 7.50%.

The infectious disease also called a communicable disease or transmissible disease is illness resulting from an infection. Infectious disease diagnostics is a process to identify the presence of foreign antigen/organisms with the help of various diagnostic tools. 

High prevalence along with the growing incidence of infectious diseases are major factors driving the global healthcare-associated infectious disease diagnostics market growth. Additionally, increasing government initiatives for the development of proper healthcare infrastructure in developing countries, technological advancements in diagnostic equipment, and high awareness about disease diagnostics in developed economies are other major factors estimated to propel the growth of the target market throughout the forecast period. However, lack of awareness about infectious disease diagnosis in emerging economies and increasing healthcare costs in developed economies are major factors hampering the growth of the global market.

Further, lack of proper reimbursement policies in developed economies and in some emerging economies is another major factor anticipated to limit the growth of the global market over the forecast period. Nevertheless, increasing adoption of technologically advanced visual diagnostic equipment in healthcare institutions in developing economies is the major and rising trend for global market growth. This is another factor projected to boost the growth of the global market in the coming years.

Healthcare-associated infectious disease diagnostics market is segmented based on infection type, product type, test type, end-user type, and region.

On the basis of infection type, the healthcare-associated infectious disease diagnostics market is segmented into urinary tract infections, surgical site infections, hospital-acquired pneumonia, bloodstream infections, gastrointestinal infections, and other healthcare-associated infections. Based on product type, the global market is segmented into consumables and analyzers/instruments. On the basis of test type, the target market is bifurcated into Traditional diagnostics and molecular diagnostics. Based on end-user type, the global market is classified into hospitals, clinics, ASCs, and others.

Regional Insights:

On the region, the healthcare-associated infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America market dominates the healthcare-associated infectious disease diagnostics market in terms of revenue currently, due to the high prevalence rate of infectious diseases coupled with the presence of a proper healthcare system in the region. The market in Europe estimates for second-largest revenue share in the global market, followed by markets in Asia Pacific, Latin America, and Middle East & Africa respectively. Asia Pacific market is expected to witness the fastest growth in terms of revenue, due to the growing incidence of infectious diseases and rise in government initiatives for the improvement of healthcare facilities in developing economies in the region.

Healthcare-associated Infectious Disease Diagnostics Market, By Infection Type:

• Urinary Tract Infections
• Surgical Site Infections
• Hospital-acquired Pneumonia
• Blood Stream Infections
• Gastrointestinal Infections
• Other Healthcare-associated Infections

Healthcare-associated Infectious Disease Diagnostics Market, By Product Type:

• Consumables

• Analyzers/Instruments

Healthcare-associated Infectious Disease Diagnostics Market, By Test Type:

• Traditional Diagnostics
• Molecular Diagnostics

Healthcare-associated Infectious Disease Diagnostics Market, By End-user:

• Hospitals
• Clinics
• ASCs
• Others

Healthcare-associated Infectious Disease Diagnostics Market, By Region:

• North America

• North America Healthcare-associated Infectious Disease Diagnostics Market, By Infection Type
• North America Healthcare-associated Infectious Disease Diagnostics Market, By Product Type
• North America Healthcare-associated Infectious Disease Diagnostics Market, By Test Type
• North America Healthcare-associated Infectious Disease Diagnostics Market, By End-user
• North America Healthcare-associated Infectious Disease Diagnostics Market, By Country
  • U.S.
  • Canada
• Europe
• Europe Healthcare-associated Infectious Disease Diagnostics Market, By Infection Type
• Europe Healthcare-associated Infectious Disease Diagnostics Market, By Product Type
• Europe Healthcare-associated Infectious Disease Diagnostics Market, By Test Type
• Europe Healthcare-associated Infectious Disease Diagnostics Market, By End-user
• Europe Healthcare-associated Infectious Disease Diagnostics Market, By Country
  • Germany
  • UK
  • FranceRussia
  • Italy
  • Rest of Europe
• Asia Pacific
• Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market, By Infection Type
• Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market, By Product Type
• Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market, By Test Type
• Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market, By End-user
• Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market, By Country
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
    • Latin America
    • Latin America Healthcare-associated Infectious Disease Diagnostics Market, By Infection Type
    • Latin America Healthcare-associated Infectious Disease Diagnostics Market, By Product Type
    • Latin America Healthcare-associated Infectious Disease Diagnostics Market, By Test Type
    • Latin America Healthcare-associated Infectious Disease Diagnostics Market, By End-user
• Latin America Healthcare-associated Infectious Disease Diagnostics Market, By Country
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market, By Infection Type
  • Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market, By Product Type
  • Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market, By Test Type
  • Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market, By End-user
  • Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market, By Country
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa

The key players operating the healthcare-associated infectious disease diagnostics market include F. Hoffmann-La Roche Ltd., Abbott Diagnostics, bioMérieux SA, Becton-Dickinson & Company, Siemens Healthineers, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories, Sysmex Corporation, Beckman Coulter, and Danaher Corporation. Prominent players operating in the target market are focusing on the strategic partnerships as well as the launching of the products in order to gain a competitive edge in the target market. For instance, in 2018, F. Hoffmann-La Roche was involved in 23 successful diagnostic partnerships, which increases its product availability to targeted consumers.

• F. Hoffmann-La Roche Ltd.
• Abbott Diagnostics
• Biomérieux SA
• Becton-Dickinson & Company
• Siemens Healthineers
• Thermo Fischer Scientific, Inc.
• Bio-Rad Laboratories
• Sysmex Corporation
• Beckman Coulter
• Danaher Corporation